PPTA Statements

PPTA is Proud to Support Rare Disease Day 2017

The Plasma Protein Therapeutics Association (PPTA) is proud to support Rare Disease Day, an annual international event that seeks to raise awareness about rare diseases and the patients and families that are affected by a rare disease.

Continue reading

  • Created on .

PPTA Statement on the Documentary “Das Geschäft mit dem Blut”

PPTA has viewed the documentary "Das Geschäft mit dem Blut" / "Le business du sang" that will air on Feb. 21, 2017 in Germany, France, and Belgium on ARTE TV. PPTA strongly objects to the content of the documentary because it is not factual and contains numerous inaccuracies and misinformation.

Continue reading

  • Created on .

Zika Virus and Plasma Protein Therapies

Updated Oct. 3, 2016

Recent scientific and public press reports have heightened awareness of the emergence of Zika virus (ZIKV) in the Americas1,2 and the causal relationship between prenatal ZIKV infection and microcephaly and other severe fetal brain defects3,4.

Continue reading

  • Created on .

PPTA Recognizes World PI Week: April 22-29, 2016

April 22, 2016—The Plasma Protein Therapeutics Association (PPTA) stands together with the global primary immunodeficiency community to promote World PI Week, a global campaign aimed to raise awareness and improve diagnosis and treatment of PI.

Continue reading

  • Created on .

PPTA Statement on MSM Donor Policy

[Blood Products Advisory Committee Meeting on December 2, 2014]

The Plasma Protein Therapeutics Association (PPTA) is the international trade association and standards-setting organization for the world’s major producers of plasma-derived and recombinant analog therapies, collectively referred to as plasma protein therapies. Plasma protein therapies are used in the treatment of a number of rare diseases.

Continue reading

  • Created on .

Ebola Virus and Plasma Protein Therapies

During the October, 21 2016, Source Board of Directors meeting, the Board agreed to remove the voluntary deferral for 60 days of donors returning from Ebola virus disease affected areas in the previous 60 days. The deferral was originally implemented on or about October 13, 2014.

Continue reading

  • Created on .

PPTA Letter to Stakeholders re: European Data Program Update

Dear PPTA Stakeholders:

I would like to provide a status report on implementation of PPTA’s European Data Program.

As you know, PPTA launched the program in November 2013 starting with the reporting of Recombinant Factor VIII data. We committed as well to soon begin reporting data on a more complete set of plasma protein therapies. Today we are able to honor that commitment. Please click here to access the data.

Continue reading

  • Created on .
Copyright © 2020 PPTA. All rights reserved. (202) 789-3100